Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential cation channel subfamily V member 5 (TRPV5) is a highly calcium-selective ion channel of the TRP family, mainly expressed in the distal convoluted tubule of the kidney, where it mediates active calcium reabsorption critical for systemic calcium homeostasis[1][2][8]. The channel is characterized by six transmembrane domains, strong calcium selectivity, and inward rectification. TRPV5 forms homo- or heterotetramers (with TRPV6). It is regulated by a variety of endogenous factors, including calmodulin (CaM, which mediates calcium-dependent inactivation), phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2, which activates the channel), long-chain coenzyme A species (LC-CoA, activating), and α-klotho (which stabilizes the channel for greater reabsorption)[1][6][8]. Genetic deletion or inactivating mutations in TRPV5 disrupt renal calcium retention, causing urinary calcium wasting, secondary hyperparathyroidism, and bone loss. Recently, TRPV5 has also been implicated in B-cell function and immune response regulation[10]. Selective inhibitors include econazole and the research compound ZINC17988990, and structure-function studies are guiding drug discovery efforts for conditions related to abnormal calcium handling[8].
Direct inhibition of channel activity (by small molecules like econazole and ZINC17988990)[1][8] Allosteric/channel pore blockade (/by inhibitors binding within the ion channels)[8] Modulation by endogenous ligands (e.g., activation by PI(4,5)P2, LC-CoA; inhibition by CaM)[6][8]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential cation channel subfamily V member 5 (TRPV5).